Carcinogenesis, Vol. 24, No. 4, 681-687,
April 2003
© 2003 Oxford University Press
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION |
Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk
1 Department of Medical Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden
2 Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden
3 International Agency for Research on Cancer, Lyon, France
4 Swedish Medical Products Agency, Uppsala, Sweden
5 To whom correspondence should be addressed Email: sara.wedren{at}mep.ki.se
Estrogen is involved in breast carcinogenesis. Hypotheses have been raised that its effect is modified by enzymes such as catechol-O-methyltransferase (COMT) that deactivate potentially genotoxic estrogen metabolites. We have investigated the association between the functional genetic Val108/158Met polymorphism in COMT and breast cancer risk in a large population-based case–control study performed in the genetically homogeneous Swedish population. We determined COMT genotype in 1534 women with invasive breast cancer and in 1504 control women and calculated odds ratios (OR) and 95% confidence intervals (CI) from logistic regression models. There was no overall association between COMT genotype and breast cancer risk. However, the L allele was associated with an increased risk for lobular breast cancer, with OR 2.0 (95% CI 1.2–3.5) for HL and 1.7 (95% CI 0.9–3.0) for LL. In exploratory subset analyses, we found no statistically significant interaction, but some indication of a positive association between HL and LL genotypes and breast cancer among women with diabetes mellitus and a negative association among nulliparous women. Based on our findings, COMT activity alone does not seem to play a major role in breast carcinogenesis, but may be of importance in certain histotypes or in conjunction with other exposures.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P.D. Pereira, C. C. Lopes, A. J. F. Matos, D. Pinto, F. Gartner, C. Lopes, and R. Medeiros Estrogens Metabolism Associated with Polymorphisms: Influence of COMT G482a Genotype on Age at Onset of Canine Mammary Tumors Vet. Pathol., March 1, 2008; 45(2): 124 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wen, Z. Ren, X. O. Shu, Q. Cai, C. Ye, Y.-T. Gao, and W. Zheng Expression of Cytochrome P450 1B1 and Catechol-O-Methyltransferase in Breast Tissue and Their Associations with Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 917 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tanaka, M. Sasaki, H. Shiina, T. Tokizane, M. Deguchi, H. Hirata, Y. Hinoda, N. Okayama, Y. Suehiro, S. Urakami, et al. Catechol-O-methyltransferase Gene Polymorphisms in Benign Prostatic Hyperplasia and Sporadic Prostate Cancer. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 238 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Wen, Q. Cai, X.-O. Shu, J.-R. Cheng, F. Parl, L. Pierce, Y.-T. Gao, and W. Zheng Cytochrome P450 1B1 and Catechol-O-Methyltransferase Genetic Polymorphisms and Breast Cancer Risk in Chinese Women: Results from the Shanghai Breast Cancer Study and a Meta-analysis Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 329 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Kok, N. C. Onland-Moret, K. M. van Asselt, C. H. van Gils, Y. T. van der Schouw, D. E. Grobbee, and P. H.M. Peeters No association of estrogen receptor {alpha} and cytochrome P450c17{alpha} polymorphisms with age at menopause in a Dutch cohort Hum. Reprod., February 1, 2005; 20(2): 536 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-H. Chen, Y.-J. Hurh, H.-K. Na, J.-H. Kim, Y.-J. Chun, D.-H. Kim, K.-S. Kang, M.-H. Cho, and Y.-J. Surh Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells Carcinogenesis, October 1, 2004; 25(10): 2005 - 2013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhu, M. R. Spitz, C. I. Amos, J. Lin, M. B. Schabath, and X. Wu An Evolutionary Perspective on Single-Nucleotide Polymorphism Screening in Molecular Cancer Epidemiology Cancer Res., March 15, 2004; 64(6): 2251 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-L. Eriksson, S. Skrtic, A. Niklason, L. M. Hulten, O. Wiklund, T. Hedner, and C. Ohlsson Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population Eur. Heart J., March 1, 2004; 25(5): 386 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Wu, C.-C. Tseng, D. Van Den Berg, and M. C. Yu Tea Intake, COMT Genotype, and Breast Cancer in Asian-American Women Cancer Res., November 1, 2003; 63(21): 7526 - 7529. [Abstract] [Full Text] [PDF]
|
|